...
首页> 外文期刊>Pain research & management: the journal of the Canadian Pain Society = journal de la socie?te? canadienne pour le traitement de la douleur >Perioperative Dexmedetomidine Fails to Improve Postoperative Analgesic Consumption and Postoperative Recovery in Patients Undergoing Lateral Thoracotomy for Thoracic Esophageal Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial
【24h】

Perioperative Dexmedetomidine Fails to Improve Postoperative Analgesic Consumption and Postoperative Recovery in Patients Undergoing Lateral Thoracotomy for Thoracic Esophageal Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial

机译:围手术期Dexmedetomidine未能改善术后镇痛消费和胸部食管癌患者患者的术后回收:随机,双盲,安慰剂对照试验

获取原文
           

摘要

Objectives . Dexmedetomidine is widely used as an adjunct to general anesthesia. In this study, we evaluated the effects of perioperative dexmedetomidine infusion on postoperative analgesia in patients undergoing lateral thoracotomy for thoracic esophageal cancer. Methods . A total of 62 patients undergoing lateral thoracotomy for thoracic esophageal cancer were randomized to receive adjuvant therapy with either dexmedetomidine (0.5 μ g/kg intravenous bolus injection for 10?min before induction of anesthesia, followed by continuous infusion of 0.2–0.4 μ g/kg/h until the end of surgery, and 0.06 μ g/kg/h for 5 days after surgery) or equal volumes of saline. Acute postoperative pain was treated with patient-controlled intravenous sufentanil and flurbiprofen axetil. The primary outcomes of this study were the numbers of analgesic requirements in the first postoperative 72?h. Results . Perioperative dexmedetomidine did not decrease the numbers of analgesic requirements in the first postoperative 72?h (dexmedetomidine group: 12.14?±?4.76, saline group: 10.89?±?5.66; p = 0.367 ). Likewise, the groups did not differ with respect to total postoperative analgesic requirements, postoperative pain, perioperative inflammation, blood cell count, incidence of adverse events, surgical recovery (assessed at postoperative days 2 and 5 using the surgical recovery scale), length of hospital stay, hospital cost, incidence of chronic pain, or quality of life. Notably, dexmedetomidine had beneficial effects on decreasing intraoperative opioid consumption and improving postoperative sleep quality. Discussion . Perioperative dexmedetomidine has limited analgesic benefits in lateral thoracotomy for esophageal cancer when added to an opioid-based multimodal anesthetic regimen but can reduce opioid consumption.
机译:目标。 Dexmedetomidine广泛用作全身麻醉的辅助。在这项研究中,我们评估了围手术期Dexmedetomidine输注对胸部食管癌后胸腔切开术患者术后镇痛的影响。方法 。总共62例接受胸部食管癌的胸腔切开术患者被随机化以接受Dexmedetomidine(0.5μg/ kg静脉注射喷射10≤min,在诱导麻醉前10〜5〜10℃,然后连续输注0.2-0.4μg/ kg / h直到手术结束,手术后5天的0.06μg/ kg / h,或等同的盐水。急性术后疼痛用患者控制的静脉内苏芬太尼和Flbiprofen Axetil进行治疗。本研究的主要结果是第一个术后72〜h的镇痛要求的数量。结果 。围手术期Dexmedetomidine没有降低第一个术后72?H(Dexmedetomidine Group:12.14〜α.4.76,盐水组:10.89?±5.66; P = 0.367)。同样,该组对术后镇痛要求,术后疼痛,围手术炎症,血细胞计数,不良事件发生,外科恢复(在术后2和5使用外科恢复规模评估)的情况下没有差异,医院的长度保持,医院成本,慢性疼痛的发病,或生活质量。值得注意的是,Dexmedetomidine对降低术中阿片类药物消费和改善术后睡眠质量的有益作用。讨论 。围手术期Dexmedetomidine在添加到基于阿片类化的多峰麻醉方案中的食管癌时,胸腔胸腺术中具有有限的镇痛益菌,但可以降低阿片类药物消费。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号